252 filings
Page 3 of 13
8-K
vbi3 5wemgx
26 May 20
Innovation Pharmaceuticals Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 (COVID-19) in a Human Cell Line
2:15pm
8-K
id7r3lb9xui y536
21 May 20
Regulation FD Disclosure
9:32am
8-K
x96ec0ehrmns
28 Apr 20
Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
9:30am
8-K
8ag9rj8xy 69y7nv3
6 Apr 20
Regulation FD Disclosure
2:21pm
8-K
dojzxed4jif jsvny89k
1 Apr 20
Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
12:00pm
8-K
0meh7 e46
6 Mar 20
Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus
12:00pm
8-K
f37e dzlqzc8nwhm
27 Feb 20
Regulation FD Disclosure
12:00pm
8-K
63vpgew8hco6k8s2iz8a
13 Feb 20
Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin
4:05pm
424B3
1knpuw 592i2ju
26 Dec 19
Prospectus supplement
5:18pm
8-K
6fkqlsb
26 Dec 19
Entry into a Material Definitive Agreement
5:16pm
8-K
7t8iovp1wn16
24 Dec 19
Departure of Directors or Certain Officers
12:00am
424B3
1amcx01ywlulm3ults
16 Dec 19
Prospectus supplement
8:31am
EFFECT
crs x4dfs
22 Oct 19
Notice of effectiveness
12:15am
POS AM
hmsv6uh
17 Oct 19
Prospectus update (post-effective amendment)
5:23pm
POS AM
86wigz9
20 Sep 19
Prospectus update (post-effective amendment)
4:35pm
8-K
z8gq8gdae
20 Sep 19
Amendments to Articles of Incorporation or Bylaws
4:33pm